Theseus Pharmaceuticals, Inc. (19)
Browse by Contract Category
Contracts
-
Description of Registrants Securities registered pursuant to Section 12 of the Securities Exchange Act of 1934
(Filed With SEC on March 10, 2022)
-
Lease Agreement, dated September 16, 2021, by and between Theseus Pharmaceuticals, Inc. and MIT 314 Main Street Leasehold LLC
(Filed With SEC on September 30, 2021)
-
2021 Employee Stock Purchase Plan and form of subscription agreement
(Filed With SEC on September 30, 2021)
-
2021 Equity Incentive Plan and forms of equity agreements thereunder
(Filed With SEC on September 30, 2021)
-
Form of Indemnification Agreement
(Filed With SEC on September 30, 2021)
-
License Agreement by and between ARIAD Pharmaceuticals, Inc. and Theseus Pharmaceuticals, Inc., dated as of June 13, 2018
(Filed With SEC on September 15, 2021)
-
Form of Registrants Common Stock Certificate
(Filed With SEC on September 30, 2021)
-
Form of Underwriting Agreement
(Filed With SEC on September 30, 2021)
-
Offer Letter, dated May 25, 2021, by and between Theseus Pharmaceuticals, Inc. and Kathy Yi
(Filed With SEC on September 15, 2021)
-
Offer Letter, dated July 1, 2021, by and between Theseus Pharmaceuticals, Inc. and Iain D. Dukes
(Filed With SEC on September 15, 2021)
-
Amended and Restated Investors Rights Agreement, dated January 22, 2021, by and among the Registrant and the other parties thereto
(Filed With SEC on September 15, 2021)
-
2018 Stock Plan and forms of equity agreements thereunder
(Filed With SEC on September 15, 2021)
-
Offer Letter, dated September 10, 2021, by and between Theseus Pharmaceuticals, Inc. and Victor M. Rivera
(Filed With SEC on September 15, 2021)
-
Offer Letter, dated September 10, 2021, by and between Theseus Pharmaceuticals, Inc. and David C. Dalgarno
(Filed With SEC on September 15, 2021)
-
Offer Letter, dated September 10, 2021, by and between Theseus Pharmaceuticals, Inc. and William C. Shakespeare
(Filed With SEC on September 15, 2021)
-
Offer Letter, dated September 10, 2021, by and between Theseus Pharmaceuticals, Inc. and Timothy P. Clackson
(Filed With SEC on September 15, 2021)
-
Incentive Bonus Plan
(Filed With SEC on September 15, 2021)
-
Compensation Program for Non-Employee Directors
(Filed With SEC on September 15, 2021)
-
Offer Letter, dated September 10, 2021, by and between Theseus Pharmaceuticals, Inc. and Bradford D. Dahms
(Filed With SEC on September 15, 2021)